Medication info

Cardip Tablet (Lercanidipine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 200501721 · Approved 2005.08.10

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily at least 15 minutes before a meal. The dose may be increased up to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become apparent. Patients whose blood pressure is not controlled with this drug may receive combination therapy with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches its peak at doses of 20 ~ 30 mg. At doses above this range, the effect is not further enhanced; instead, adverse reactions increase. ○ Elderly patients : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is needed when starting treatment in elderly patients. ○ Patients with hepatic or renal impairment : Patients with mild to moderate hepatic or renal impairment require special caution when starting treatment. Although the usual dosage regimen for these patients is unchanged, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased; therefore, dose adjustment should be considered. Do not administer this drug to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medicine is used for the treatment of essential hypertension that is classified as mild to moderate.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily at least 15 minutes before a meal. The dose may be increased up to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become apparent. Patients whose blood pressure is not controlled with this drug may receive combination therapy with a beta-blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches its peak at doses of 20 ~ 30 mg. At doses above this range, the effect is not further enhanced; instead, adverse reactions increase. ○ Elderly patients : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is needed when starting treatment in elderly patients. ○ Patients with hepatic or renal impairment : Patients with mild to moderate hepatic or renal impairment require special caution when starting treatment. Although the usual dosage regimen for these patients is unchanged, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased; therefore, dose adjustment should be considered. Do not administer this drug to patients with severe hepatic or renal impairment.

Precautions

This medication should not be administered to certain patients. For instance, individuals who are allergic to this medication or similar drugs, pregnant women or those who may become pregnant, and nursing women should not use it. Patients with heart problems, particularly those with left ventricular outflow obstruction, untreated congestive heart failure, or unstable angina should also not take this medication. Patients with severe liver or kidney impairment, recent myocardial infarction, those undergoing dialysis, and children or adolescents under 18 years of age should not use this medication. Additionally, this medication contains lactose, so patients with lactose intolerance or certain genetic disorders should refrain from taking it. Patients with syndrome of inappropriate secretion of antidiuretic hormone, left ventricular dysfunction, ischemic heart disease, mild to moderate liver dysfunction or kidney disorders, a history of angina, those who consume alcohol frequently, and the elderly should take this medication cautiously. Due to its vasodilatory effect, this medication may cause symptoms such as facial flushing, swelling, and rapid heartbeat. Rarely, hypotension, chest pain, or angina may occur. Neurological symptoms such as headache, dizziness, weakness, fatigue, and drowsiness may also be experienced, along with gastrointestinal symptoms such as indigestion, nausea, vomiting, abdominal pain, and diarrhea. It is important to regularly monitor liver function because this medication may affect it; if abnormalities are found, discontinuation of use is necessary. This medication may interact with other drugs, especially those affecting the enzyme CYP3A4, which is involved in drug metabolism in the liver. Pregnant or nursing women should not take this medication, and those planning to become pregnant should also avoid using it. Its safety has not been established for use in children and adolescents, so it should not be administered to them. Elderly patients need to exercise special caution when initiating treatment with this medication. In cases of overdose, severe hypotension or cardiac issues may arise, requiring immediate medical attention and treatment as directed by healthcare professionals. This medication should be kept out of reach of children, and transferring it to other containers is not advisable as it can affect the maintenance of quality.

Side effects

Flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, weakness, fatigue, drowsiness, neurosis, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, increased serum levels of liver aminotransferases, polyuria, nocturia, gingival hyperplasia, rash, myalgia, tremors, insomnia, dry mouth, hand tingling, cough, abdominal bloating, erectile dysfunction, arrhythmia, cold sweat, skin tingling, premature contractions, tongue stiffness, increased ventricular premature contractions, shortness of breath, gastrointestinal disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture. Additionally, it is advisable to keep the medication at room temperature between 1 to 30 degrees Celsius, not in excessively hot or cold places.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.